Psoriasis

Patients with rosacea, alopecia areata, psoriasis or atopic dermatitis all face an elevated risk for cardiovascular disease, according to a study.

In this video, Tracey Henslee, CRNP, discusses the treatment of pustular psoriasis, a highlight of this year’s Fall Clinical Dermatology Conference for PAs & NPs held in Orlando.

Eli Lilly and Company will acquire DICE Therapeutics at the end of the third quarter of 2023, according to an Eli Lilly and Company press release.

Women with vs. without psoriasis are at an increased risk for pregnancy loss, and women with moderate to severe psoriasis may also experience lower fertility rates, according to a study.

At the 2023 European Congress of Rheumatology, Amgen presented study results evaluating the use of Otezla for the treatment of psoriatic arthritis, according to a company press release.

Spatial transcriptomic profiling showed that lesional and distal, nonlesional areas in patients with psoriasis stratify by disease severity and not by the presence of disease, according to a study from NYU Langone Health.

The FDA has given the green light to a new autoinjector option for the interchangeable adalimumab biosimilar Cyltezo, just weeks ahead of its scheduled debut in the United States, according to a press release from the manufacturer.

Three-quarters of patients with generalized pustular psoriasis demonstrated response to treatment with an interleukin-36-targeted therapy as early as 4 weeks, according to a study.

DESTIN, Fla. — Understanding which psoriatic arthritis disease domains are most important to the patient may help guide therapeutic decision-making, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

Vitamin D administered during winter to a cohort of patients with psoriasis in Norway failed to best placebo in disease severity score, according to a study.